16th week of 2016 patent applcation highlights part 24 |
Patent application number | Title | Published |
20160108325 | PROCESS FOR HYDROTREATING A COKER KEROSENE STREAM TO PROVIDE A FEED STREAM FOR A PARAFFIN SEPARATION ZONE - A process for hydrotreating a coker kerosene feed stream to produce a feed stream for a paraffin separation zone. An effluent stream from a hydrotreating zone is passed to an aromatic separation zone to remove aromatics from the effluent stream form the hydrotreating zone and provide an aromatic lean stream. The aromatic lean stream may be passed to the paraffin separation zone to separate normal paraffins from non-normal paraffins. The separated aromatics can be passed to an aromatic processing zone to, for example, to produce xylene or other desirable aromatic hydrocarbons. | 2016-04-21 |
20160108326 | CLOUD POINT IMPROVEMENT FOR PARTIAL CONVERSION HYDROCRACKING UNITS - Methods and apparatus for improving the cold flow properties of diesel are described. The methods include hydrocracking a hydrocarbon feed to provide a reactor effluent comprising a product mixture comprising diesel, kerosene, and naphtha, and unconverted feed. The reactor effluent is separated in an enhanced hot separator into an overhead vapor stream comprising the product mixture and a liquid bottoms stream comprising the unconverted feed. The overhead vapor stream is contacted with a dewaxing catalyst in a finishing reaction zone to convert a portion of n-paraffins in the product mixture to iso-paraffins. The effluent from the finishing reaction zone is separated in a high pressure separator into an overhead stream comprising gases and a liquid stream comprising the product mixture. The liquid stream from the high pressure separator is separated into at least a diesel stream in a fractionation zone. | 2016-04-21 |
20160108327 | CHEMICAL INHIBITORS WITH SUB-MICRON MATERIALS AS ADDITIVES FOR ENHANCED FLOW ASSURANCE - Methods may include admixing an additive composition with a hydrocarbon fluid, wherein the additive composition contains at least one inhibitor and at least one sub-micron particle. Additional methods may include providing an additive composition containing at least one inhibitor and at least one sub-micron particle; adding the additive composition to a fluid capable of precipitating at least one of at least of asphaltenes, wax, scale, and gas hydrates; and transporting the fluid containing the additive composition. | 2016-04-21 |
20160108328 | SORBENT CONTAINING ENGINEERED FUEL FEED STOCK - Disclosed are novel engineered fuel feed stocks, feed stocks produced by the described processes, methods of making the fuel feed stocks, methods of producing energy from the fuel feed stocks. Components derived from processed MSW waste streams can be used to make such feed stocks which are substantially free of glass, metals, grit and noncombustibles and contain a sorbent. These feed stocks are useful for a variety of purposes including as gasification and combustion fuels. In addition, one or more sorbents can be added to the feed stocks in order to reduce the amount of a variety of pollutants present in traditional fuel and feed stocks, including, but not limited, sulfur and chlorine. Further, these feed stocks with added sorbent can mitigate corrosion, improve fuel conversion, extend power generating plant lifetime, reduce ash slagging, and reduced operating temperature. | 2016-04-21 |
20160108329 | SMALL INTERNAL COMBUSTION ENGINE FUELS - Disclosed herein are motor fuels providing enhanced properties for use with 2-stroke and 4-stroke engines. The fuels comprise isooctane, alkylate, mesitylene, isopentane and butane, and optionally a special lube oil premixed in solution. | 2016-04-21 |
20160108330 | Synthesis of Liquid Fuels and Chemicals From Oxygenated Hydrocarbons - Processes and reactor systems are provided for the conversion of oxygenated hydrocarbons to hydrocarbons, ketones and alcohols useful as liquid fuels, such as gasoline, jet fuel or diesel fuel, and industrial chemicals. The process involves the conversion of mono-oxygenated hydrocarbons to aromatics and gasoline range hydrocarbons where the oxygenated hydrocarbons are derived from biomass. | 2016-04-21 |
20160108331 | BETAINE COMPOUNDS AS ADDITIVES FOR FUELS - The use of betaine compounds of the formula R | 2016-04-21 |
20160108332 | FUEL COMPOSITION AND METHOD OF FORMULATING A FUEL COMPOSITION TO REDUCE REAL-WORLD DRIVING CYCLE PARTICULATE EMISSIONS - In order to blend fuels to meet specific regulatory and industry requirements, for instance octane requirements, different octane blending components can be used. One added component includes a composition of higher aromatics content. Unfortunately, this aromatic content may increase the particulate emissions of an internal combustion engine when the high aromatic fuel is combusted in that engine. As explained herein, reducing the aromatics content and replacing that octane increasing requirement with an alternative octane enhancer results in a formulated fuel that will have lower particulate emissions in the real-world driving of that engine as compared with a fuel having higher aromatic content. | 2016-04-21 |
20160108333 | INTEGRATED PROCESS FOR DIALKYLDISULFIDES TREATMENT - The invention relates to a method for treating a hydrocarbon gas stream containing H2S and mercaptans, in which dialkyldisulfides are produced then removed by hydrogenation, as well as a device for carrying out said method, | 2016-04-21 |
20160108334 | USE OF O/W EMULSIONS FOR CHAIN LUBRICATION - The invention relates to the use of an O/W emulsion, in particular a PIT emulsion, for lubricating conveyor belt systems in food industries as well as a lubricant concentrate based on an O/W emulsion, in particular a PIT emulsion, of wax esters. | 2016-04-21 |
20160108335 | Lubricant Compositions Including Alpha-Olefin Copolymers - A lubricant composition may include a copolymer having constitutional units formed from monomers including an alpha-olefin and an α-ester-alk-ω-ene molecule, where the composition has a kinematic viscosity at 100° C. of at most 20 centistokes, or of at least 40 centistokes. A lubricant composition may include a copolymer having constitutional units formed from monomers including an alpha-olefin, an α-ester-alk-ω-ene molecule and an α-(carboxylic acid)-alk-ω-ene molecule, where the composition has a viscosity that varies as the molar ratio of the α-ester-alk-ω-ene molecule α-(carboxylic acid)-alk-ω-ene molecule in the monomers varies. | 2016-04-21 |
20160108336 | DIESEL ENGINE OIL COMPOSITION FOR IMPROVING FUEL EFFICIENCY AND ENDURANCE PERFORMANCE - Disclosed is a novel diesel engine oil composition for fuel efficiency and endurance performance. The diesel engine oil composition may maximize frictional resistance and wear resistance by facilitating the formation of a lubricating film on a metal surface, extend an oil change cycle with excellent engine protection ability, and improve fuel efficiency due to friction reduction. The diesel engine oil composition include: base oil; a calcium-based or magnesium-based sulfonate detergent dispersant; a viscosity index improver selected from the group consisting of a diene copolymer, a polystyrene-diene copolymer and a hydrogenated polystyrene-diene copolymer; and a low friction agent including molybdenum dithiocarbamate (MoDTC) and glycerol monooleate (GMO). | 2016-04-21 |
20160108337 | Lubricating Composition and Method of Lubricating a Transmission - The present invention relates to a lubricating composition comprising: (a) an oil of lubricating viscosity having a kinematic viscosity at 100° C. of 2.8 to 3.6 cSt (mm2/s) and a viscosity index of 104 to 130; (b) 1.2 to 5.0 wt % of at least one borated dispersant, wherein at least one borated dispersant is further functionalised with a sulphur or phosphorus moiety; (c) a calcium-containing detergent present in an amount to deliver at least 110 ppm to 700 ppm of calcium; (d) at least two phosphorus-containing compounds present in an amount to deliver 360 to 950 ppm of phosphorus; and (e) 0.1 wt % to 5 wt % of a linear polymer viscosity modifier having dispersant functionality. The invention further provides a method of lubricating a transmission with the lubricating composition disclosed wherein. | 2016-04-21 |
20160108338 | PROCESS FOR DEGUMMING OILS - A multi-stage agitation system is used for degumming vegetable oil to increase yield and reduce phosphatides. A high-shear mixing phase, that can include multiple stages, subjects an oil mixed with acid and base to a shear rate of greater than 15,000 s | 2016-04-21 |
20160108339 | CONTROLLED RELEASE DUAL WALLED MICROCAPSULES - A method of forming dual melamine/acrylic walled microcapsules having improved physical properties and release control as well as the microcapsules formed by the process wherein the capsule wall is formed by the use of select (meth)acrylate monomers and/or oligomers and/or select self-condensing melamine resins. | 2016-04-21 |
20160108340 | CONTROLLED RELEASE MICROCAPSULES - A method of forming microcapsules having improved physical properties and release control as well as the microcapsules formed by the process wherein the capsule wall is formed by the concurrent polymerization of monomers, oligomer and/or prepolymers on the inside of the capsule wall and different monomers, oligomers and/or prepolymers on the exterior of the capsule wall as it forms. | 2016-04-21 |
20160108341 | ODORANT KETONES - The present invention concerns compounds of formula (I) in the form of any one of its stereoisomers or a mixture thereof, and wherein each R, independently from each other, represents a hydrogen atom or a methyl or ethyl group provided that at least one of said R groups represents a methyl or ethyl group, and R | 2016-04-21 |
20160108342 | 3-(4-ISOBUTYL-2-METHYLPHENYL) PROPANAL AS PERFUME INGREDIENT - A compound according to the formula (I) | 2016-04-21 |
20160108343 | METHOD OF PRODUCING ESTOLIDE USING LINKING AGENT - Disclosed is a method of producing an estolide, including a) converting biomass-derived oil into a fatty acid mixture, b) separating the fatty acid mixture into a C16 saturated fatty acid and a C18 unsaturated fatty acid, c) converting the C16 saturated fatty acid into a C15 or C16 linear internal olefin, d) subjecting the C15 or C16 linear internal olefin to an estolide reaction using a linking agent, thus obtaining an estolide A, e) subjecting the C18 unsaturated fatty acid to partial hydrogenating to increase the amount of oleic acid, and f) subjecting the oleic acid to an estolide reaction using a linking agent and then esterification, thus obtaining an estolide B. | 2016-04-21 |
20160108344 | PROCESS AND SYSTEM FOR PRODUCING A FATTY ACID ALKYL ESTER - A process and a system for producing a fatty acid alkyl ester from an alcohol and a feedstock containing transesterifiable lipids are provided. | 2016-04-21 |
20160108345 | Detergent composition for treating fabrics with insecticides - A detergent composition including permethrin is disclosed that is particularly adapted to launder clothing or other personal fabrics. Laundering clothing with composition provides effective insect repellant properties to the clothing. The detergent composition is especially useful for control of mosquitoes and other insects, thereby reducing the incidence of malaria and other diseases. | 2016-04-21 |
20160108346 | MICROCAPSULES CONTAINING A GAS-GENERATING PHOTOLABILE KETOACID OR KETOESTER AND USES THEREOF - The present invention relates to water-dispersable microcapsules comprising an oil phase, e.g. a perfume, containing a photolabile α-ketoacid or α-ketoester capable of generating a gas upon exposure to light. The gas is able to cause an extension or the breaking of the microcapsule allowing the release of the oil phase and thus increasing the long-lastingness of the odor perception. The present invention concerns also the use of said microcapsules in perfumery as well as the perfuming compositions or perfumed articles comprising the invention's microcapsules to provide a prolonged release of fragrant molecules. | 2016-04-21 |
20160108347 | ORGANIC CLEANING COMPOSITION - Organic cleaner/detergent compositions, formulations and solutions, and methods of cleaning using such compositions, formulations and solutions and manufacturing such compositions, formulations and solutions are disclosed. More particularly, compositions; formulations and solutions used for the cleaning and/or cleansing of a variety of industrial, domestic and/or communal hard surfaces, fiber/soft surfaces, including all natural, organic, synthetic and blended fibers, and organic surfaces, including, but not limited to, human skin and hair and animal skin and hair are disclosed. Such compositions, formulations and solutions are useful as laundry detergents, automatic dishwasher detergents, hard surface cleaners, hand soaps, human shampoos, and animal shampoos. | 2016-04-21 |
20160108348 | COMPOSITIONS FOR REMOVING RESIDUES AND RELATED METHODS - Compositions for removing residues from a semiconductor structure. The compositions comprise water, a base, a polydentate chelator, a degasser, and a fluorine source. The compositions comprise greater than or equal to approximately 99 wt % of the water and are formulated to exhibit a pH of from approximately 10.0 to approximately 12.0. Methods of forming and using the compositions are also disclosed. | 2016-04-21 |
20160108349 | Liquid Catalyzing System - The present invention provides a liquid catalyzing system for aging a liquid, such as alcoholic liquid, vinegar and soy sauce. In the present invention, a plurality of nano metal flakes are adopted as the catalyst and a liquid catalyzing system is particularly designed in the present invention for rapidly aging the liquid. By using the liquid catalyzing system, the liquid can be evenly mixed with the nano metal flakes in a reaction space constructed by a framework and a filter; in addition, a disturb gas is inputted to the reaction space through a gas circulation loop connecting with the framework for treating a liquid flow disturbance to the liquid and the nano metal flakes, so as to accelerate a catalytic reaction resulted from the nano metal flakes to the liquid. | 2016-04-21 |
20160108350 | LIQUID DELIVERY DEVICE AND CELL CULTURE DEVICE USING SAME - The liquid feeder includes a liquid feeding pipe having a liquid introduce port and a liquid discharge port, a housing container which holds liquid to be introduced from the liquid introduce port, a liquid feed mechanism which feeds the liquid in the liquid feeding pipe to the liquid discharge port, a gas introduce unit which introduces gas into the liquid feeding pipe, and a liquid level detection unit which detects an advancing liquid level of the liquid to be fed in the liquid feeding pipe. The gas introduce unit is connected to a branch part provided in the liquid feeding pipe on the upstream side of the liquid feed mechanism. The liquid level detection unit is provided on the downstream side of the branch part. | 2016-04-21 |
20160108351 | SIMPLE ANIMAL CELL CULTURE DEVICE AND METHOD FOR CULTURING ANIMAL CELLS USING SAME - The present invention relates to a simple animal cell culture device and a method for culturing animal cells using the same, and provides a simple animal cell culture device comprising: a culture vessel for holding a culture medium; an animal cell reservoir coupled to the upper portion of the culture vessel; a cell support housed on the inside of the animal cell reservoir and having animal cells adhered thereto; and a cover for covering the top of the culture vessel. | 2016-04-21 |
20160108352 | CULTURE VESSEL AND METHOD FOR CULTURING BIOLOGICAL CELLS IN HANGING DROPS - A culture vessel ( | 2016-04-21 |
20160108353 | CULTURE OBSERVATION APPARATUS AND CULTURE OBSERVATION SYSTEM - An object is to lessen a troublesome checking task during cell culturing. A culture observation apparatus of the present invention includes: a light source unit that radiates illumination light onto the inside of a transparent culture vessel from a side surface of the culture vessel; an image acquisition unit that images, of the illumination light radiated from the light source unit, scattered light emitted from the inside of the culture vessel to acquire images; and a transmission unit that sends the images acquired by the image acquisition unit to the outside. The image acquisition unit includes a sensor array that has a plurality of sensors arranged in at least one line over approximately the entire length in one direction of a bottom surface of the culture vessel and a movement mechanism that relatively moves the sensor array and the culture vessel in a direction intersecting the array direction of the sensors and extending along the bottom surface. | 2016-04-21 |
20160108354 | SYSTEM FOR SWITCHING OVER THE EXHAUST AIR OF A BIOREACTOR | 2016-04-21 |
20160108355 | SACCHARIFICATION REACTION APPARATUS - A saccharification-reaction apparatus includes: a reactor which causes a saccharification-reaction of a raw material; and a raw material charging device which charges the raw material into the reactor at a predetermined interval; the reactor includes: a heating steam feeder which increases a temperature of the raw material charged from the charging device to a saccharification-reaction temperature; and a feeding mechanism which sequentially feeds each of the charged raw materials toward an outlet-port in a predetermined short period of time while causing the saccharification-reaction of each raw material under a high temperature and pressure; the raw material charging-device charges into the reactor, the raw material with a suitable bulk density for a saccharification-reaction speed of the reactor; in this manner, the saccharification-reaction apparatus charges the raw material in a hydrolytic saccharification state into the reactor by the raw material charging device; and hydrolytically saccharifying the raw material efficiently in the reactor. | 2016-04-21 |
20160108356 | MIXING AND FILTERING SYSTEM AND METHOD - An apparatus for growing and separating cells or micro carriers from fluid medium in an aseptic environment, has a sealed, air and liquid tight, container having a port to allow for the introduction of fluid, gas or components, a filter with a filtration medium mounted centrally around an axis extending through the container, a mixing assembly that rotates around the filtration medium to allow for suspension of media or agitation thereof, and the mixing assembly has vanes containing a magnetic unit in a lower portion thereof that allows for coupling to a stir plate for driving the vanes of the mixing assembly. The vanes are preferably suspended by a central bearing located above the filter, and preferably the vanes extend downward to proximate the bottom of the container to the same extent as the filter and a diptube located along the axis of the filter and vanes. | 2016-04-21 |
20160108357 | METHODS OF CULTURING A CELL - Provided herein are methods of culturing a mammalian cell that include culturing a mammalian cell comprising a recombinant protein-encoding nucleic acid in a liquid culture medium containing 0.1 g/L or more processed Bovine Serum Albumin (BSA) under conditions sufficient to produce the recombinant protein, where the processed BSA is present in and/or added to the liquid culture medium prior to and/or during the culturing step. | 2016-04-21 |
20160108358 | METHOD OF ASSEMBLING A 3D TISSUE CULTURING SCAFFOLD - A continuous device for culturing mammalian cells in a three-dimensional structure for the transplantation or implantation in vivo is described. The culturing device comprises (a) a scaffold formed by a matrix of interconnected growth surfaces spaced at regular intervals and (b) a fluid distribution means at the inlet and the exit of the growth areas. The device is particularly useful for culturing bone cells for dental implants or bone reconstruction. | 2016-04-21 |
20160108359 | AVIAN CELLS FOR IMPROVED VIRUS PRODUCTION - The present Invention provides as avian cell in which the expression or activity of one or more of the following genes, or a homologue thereof: Chicken IFITM 1 (SEQ ID No. 1); Chicken IFITM2 (SEQ ID No. 2) and Chicken IFITM3 (SEQ ID No. 3) is reduced. The invention also provides methods for passaging viruses in avian cells, embryos and/or avian cell lines which have reduced expression of one or more IFITM genes and methods which involve investigating the sequence of one or more of the following genes, or a homologue thereof: Chicken IFITM1 (SEQ ID No. 1); Chicken IFITM2 (SEQ ID No. 2) and Chicken IFITM3 (SEQ ID No. 3). | 2016-04-21 |
20160108360 | GENETIC MODIFICATION OF RATS - Compositions and methods are provided for making rat pluripotent and totipotent cells, including rat embryonic stem (ES) cells. Compositions and methods for improving efficiency or frequency of germline transmission of genetic modifications in rats are provided. Such methods and compositions comprise an in vitro culture comprising a feeder cell layer and a population of rat ES cells or a rat ES cell line, wherein the in vitro culture conditions maintain pluripotency of the ES cell and comprises a media having mouse leukemia inhibitory factor (LIF) or an active variant or fragment thereof. Various methods of establishing such rat ES cell lines are further provided. Methods of selecting genetically modified rat ES cells are also provided, along with various methods to generate a transgenic rat from the genetically modified rat ES cells provided herein. Various kits and articles of manufacture are further provided. | 2016-04-21 |
20160108361 | MEDIA COMPOSITIONS FOR NEURONAL CELL CULTURE - Provided herein are, inter alia, are media compositions useful for culturing neural cells. In particular, the compositions provided herein mimic important physiological conditions in the living brain and sustain neural activity. The media compositions provided herein improve the efficiency of human neuron maturation and promote synaptic function in long-term in vitro cultures. | 2016-04-21 |
20160108362 | Culture medium and method for inducing differentiation of pluripotent stem cells into neuroepithelial cells - The present invention discloses a culture medium and method for inducing differentiation of pluripotent stem cells into neuroepithelial cells. The culture medium comprises at least two agents for neural induction, wherein the agents includes a Wnt signal agonist and a Smad2/3 inhibitor and the culture medium is a feeder free culture. The method is to culture pluripotent stem cells in the culture medium to differentiate into neuroepithelial cells. The neuroepithelial cells can further differentiate into mature neurons for practical applications, including regeneration medicine and drug discovery for neural disorders. | 2016-04-21 |
20160108363 | USE OF LIFR OR FGFR3 AS A CELL SURFACE MARKER FOR ISOLATING HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS - The present invention provides LIFR and FGFR3 as cell surface markers for isolating human cardiomyogenic ventricular progenitor cells, in particular progenitor cells that preferentially differentiate into cardiac ventricular muscle cells. Thus, the invention provides human ventricular progenitor (HVP) cells. The invention provides in vitro methods of the separation of Islet 1+ LIFR+ ventricular progenitor cells and/or Islet 1+/FGFR3+ ventricular progenitor cells and/or Islet 1+/LIFR+/FGFR3+ ventricular progenitor cells, and the large scale expansion and propagation thereof. Large clonal populations of isolated LIFR+ and/or FGFR3+ ventricular progenitor cells are also provided. Methods of in vivo use of LIFR+ and/or FGFR3+ ventricular progenitor cells for cardiac repair or to improve cardiac function are also provided. Methods of using the LIFR+ and/or FGFR3+ ventricular progenitor cells for cardiac toxicity screening of test compounds are also provided. | 2016-04-21 |
20160108364 | PLURIPOTENT HUMAN ADIPOSE ADULT STEM CELLS: ISOLATION, CHARACTERIZATION AND CLINICAL IMPLICATIONS - Methods for the efficient isolation and use of pluripotent adipose-derived stem cells (PASCs) are provided. In certain embodiments the methods involve providing an adipose tissue sample from which the stromal vascular fraction is co-cultured with the adipocyte fraction. PASCs can be isolated with a high degree of purification without requiring an additional cell enrichment process (e.g. cell sorting). PASCs and their conditioned media can be used for tissue regeneration within hours of harvesting the adipose tissue, and without requiring cell expansion. PASCs can grow as floating individual cells, as clusters of cells, or attached to surface(s) of the culture vessel. PASCs do not produce teratomas in vivo, nor do they induce immunorejection upon transplantation, and they achieve a high efficiency in grafting. The cells and compositions can be used for cell therapy and to screen new drugs. | 2016-04-21 |
20160108365 | MAINTENANCE OF GENOMIC STABILITY IN CULTURED STEM CELLS - The present application relates to methods and compositions for the generation of therapeutic cells having reduced incidence of karyotypic abnormalities. In several embodiments cardiac stem cells are cultured in an antioxidant-supplemented media that reduces levels of reactive oxygen species, but does not down regulate DNA repair mechanisms. In several embodiments, physiological oxygen concentrations are used during culture in order to increase the proliferation of stem cells, decrease the senescence of the cells, decrease genomic instability, and/or augment the functionality of such cells for cellular therapies. | 2016-04-21 |
20160108366 | Method for Inducing Exocrine Pancreatic Cells - An object of the present invention is to provide a method for inducing the differentiation of pancreatic precursor cells into exocrine pancreatic cells. The above object is achieved by providing a method for inducing the differentiation of pancreatic precursor cells into exocrine pancreatic cells using a culture solution containing a histone deacetylase inhibitor and/or a ligand protein for a Notch signal, and a protein kinase C activator. | 2016-04-21 |
20160108367 | MDCK-DERIVED CELL STRAIN SUSPENSION-CULTURED IN PROTEIN-FREE MEDIUM AND METHOD FOR PROLIFERATING VIRUS USING CELL STRAIN - The present invention relates to a novel MDCK-derived cell line capable of being suspension-cultured in a protein-free medium and a method for proliferating a virus using the MDCK-derived cell line to produce a vaccine. The novel MDCK-derived cell line exhibits high and uniform productivity for various viruses, while causing less viral antigenic variations with low tumorigenicity, and thus can be useful in producing viruses used for vaccines. | 2016-04-21 |
20160108368 | EXOSOMES FROM CLONAL PROGENITOR CELLS - The invention provides methods, compositions, uses and kits relating to exosomes isolated from progenitor cells. | 2016-04-21 |
20160108369 | METHODS AND COMPOSITIONS FOR GENERATING OR MAINTAINING PLURIPOTENT CELLS - Methods and compositions are provided for generating or maintaining human iPS cells in culture. Methods include the use of a low osmolality medium to make human iPS cells, or use of a low osmolality medium to maintain human iPS cells. Methods for making targeted genetic modification to human iPS cells cultured in low osmolality medium are also included. Compositions include human iPS cells cultured and maintained using the low osmolality medium defined herein. | 2016-04-21 |
20160108370 | REPROGRAMMING OF AGED ADULT STEM CELLS - A method comprising (a) obtaining young adult stem cells (YASC) from a first subject; (b) lysing the YASC to generate a lysate comprising an intracellular matrix (ICM) and other cellular components; (c) filtering the lysate through a filter having a membrane size of equal to or less than 0.4 micron to obtain a filtrate; and (d) applying the filtrate to a culture of aged adult stem cells (AASC) for a time period ranging from about 24 hours to about 30 days to generate a reprogrammed AASC (R-AASC) wherein the AASC were obtained from a second subject and wherein the R-AASC when infused into a breast cancer stem model results in a reduced number of breast cancer cells in bone marrow in comparison to a breast cancer stem model having AASC that have not been reprogrammed. | 2016-04-21 |
20160108371 | RECOMBINANT VACCINIA VIRUS DERIVED FROM KVAC103 STRAIN - Disclosed herein is a novel recombinant virus vector derived from the attenuated vaccinia virus strain KVAC103. The recombinant virus vector is obtained by inserting an exogenous gene into the KVAC103 and may be used as a safe vaccine delivery vehicle in mammals. Particularly, recombinant viruses obtained by rescuing some of the genes deleted from the parent virus have an enhanced ability to proliferate in cells being cultured, and thus are easily produced. In addition, the recombinant viruses express an increased level of an exogenous antigen, and thus has enhanced immunogenic efficacy. Such recombinant virus vectors may be used in vaccines for preventing diseases, therapeutic vaccines, and molecular biological studies. | 2016-04-21 |
20160108372 | PESTIVIRUS REPLICONS PROVIDING AN RNA-BASED VIRAL VECTOR SYSTEM - Replicons of pestiviruses, in particular replicons of swine fever virus, are engineered to have a defective replication thereby having lost infectivity, and further containing a foreign gene. A replicon contains all the genetic information required for its replication, but lacks essential codons or all codons of at least one of the genes encoding the viral structural proteins E1, E2, E | 2016-04-21 |
20160108373 | Proviral Plasmids and Production of Recombinant Adeno-Associated Virus - Proviral plasmids contain a modular gene expression cassette with one or a combination of (i) a wildtype 5′ AAV2 ITR sequence flanked by unique restriction sites that permit ready removal or replacement of said ITR; (ii) a promoter flanked by unique restriction sites that permit ready removal or replacement of the entire promoter sequence; (iii) a polylinker sequence that permits insertion of a gene coding sequence without modification thereof, wherein the gene is operatively linked to, and under the regulatory control of, the aforementioned promoter; (iv) a bovine growth hormone polyadenylation sequence flanked by unique restriction sites that permit ready removal or replacement of said polyA sequence; and (v) a wildtype 3′ AAV2 ITR sequence flanked by unique restriction sites that permit ready removal or replacement of the 3′ ITR. These plasmids enable rapid manipulation of the components of the cassette, e.g., rapid mutation and/or replacement of any component, and thereby increase the efficiency of recombinant viral vector, e.g., rAAV, production. | 2016-04-21 |
20160108374 | CYTOCHROME P450 AND CYTOCHROME P450 REDUCTASE POLYPEPTIDES, ENCODING NUCLEIC ACID MOLECULES AND USES THEREOF - Provided are cytochrome P450 polypeptides, including cytochrome P450 santalene oxidase polypeptides, cytochrome P450 bergamotene oxidase polypeptides and cytochrome P450 reductase polypeptides. Also provided are nucleic acid molecules encoding the cytochrome P450 polypeptides. Cells containing the nucleic acids and/or the polypeptides are provided as are methods for producing terpenes, such as santalols and bergamotols, by culturing the cells. | 2016-04-21 |
20160108375 | CHEMILUMINESCENT WETNESS INDICATOR FOR ABSORBENT PRODUCTS - Disclosed herein are fluff pulp compositions, absorbent articles comprising the fluff pulp compositions, and related methods. The fluff pulp compositions comprise a chemiluminescent system configured to produce visible light upon contact with an aqueous system. Representative absorbent articles include disposable diapers and adult incontinence products. Representative chemiluminescent systems include bioluminescent systems. | 2016-04-21 |
20160108376 | ABHD5 AND PARTIAL HDAC4 FRAGMENTS AND VARIANTS AS A THERAPEUTIC APPROACH FOR THE TREATMENT OF CARDIOVASCULAR DISEASES - The present invention relates to Abhydrolase containing domain 5 (ABHD5) and N-terminal fragments of HDAC4 (HDAC4-NT) and variants of the aforementioned peptides for the treatment and prevention of heart failure. The present invention further provides vectors for the cardiomyocyte-specific expression of said peptides and a test system comprising ABHD5 for the identification of novel compounds which are useful for the treatment of heart failure. | 2016-04-21 |
20160108377 | MODIFIED FORMS OF PSEUDOMONAS EXOTOXIN A - exotoxin A or “PE” is a 66 kD, highly potent, cytotoxic protein secreted by the bacterium | 2016-04-21 |
20160108378 | Inhibition of AXL Signaling in Anti-Metastatic Therapy - Compositions and methods are provided for alleviating cancer in a mammal by administering a therapeutic dose of a pharmaceutical composition that inhibits activity of AXL protein activity, for example by competitive or non-competitive inhibition of the binding interaction between AXL and its ligand GAS6. | 2016-04-21 |
20160108379 | ACTRIIB-FC POLYNUCLEOTIDES, POLYPEPTIDES, AND COMPOSITIONS - In certain aspects, the present invention provides compositions and methods for modulating (promoting or inhibiting) growth of a tissue, such as bone, cartilage, muscle, fat, and/or neuron. The present invention also provides methods of screening compounds that modulate activity of an ActRII protein and/or an ActRII ligand. The compositions and methods provided herein are useful in treating diseases associated with abnormal activity of an ActRII protein and/or an ActRII ligand. | 2016-04-21 |
20160108380 | FUSION PROTEINS AND METHODS THEREOF - The invention discloses oncogenic fusion proteins. The invention provides methods for treating gene-fusion based cancers. | 2016-04-21 |
20160108381 | DNA POLYMERASES AND MUTANTS THEREOF - The present invention provides polypeptides having a nucleotide polymerase activity and method of enhancing polymerase activity. The polypeptides of the present invention may possess both a DNA-dependent DNA polymerase activity and an RNA-dependent DNA polymerase activity, i.e., a reverse transcriptase activity. The polypeptides of the present invention may be used in any application including, but not limited to, DNA sequencing reactions, amplification reactions, cDNA synthesis reactions, and combined cDNA synthesis and amplification reactions, e.g., RT-PCR. | 2016-04-21 |
20160108382 | MODIFIED TEMPLATE-INDEPENDENT ENZYMES FOR POLYDEOXYNUCLEOTIDE SYNTHESIS - The invention includes methods for identifying polymerases, such as modified terminal nucleotidyl transferases (TdT), that are capable of binding nucleotides comprising removable 3′-O-blocking moieties to a nucleic acid initiator, without the use of a template. The invention further includes the identified polymerases, and methods of using the polymerases for de novo synthesis of predetermined oligonucleotide sequences. | 2016-04-21 |
20160108383 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM - Provided are hydrolases, including lipases, saturases, palmitases and/or stearatases, and polynucleotides encoding them, and methods of making and using these polynucleotides and polypeptides. Further provided are polypeptides, e.g., enzymes, having a hydrolase activity, e.g., lipases, saturases, palmitases and/or stearatases and methods for preparing low saturate or low trans fat oils, such as low saturate or low trans fat animal or vegetable oils, e.g., soy or canola oils. | 2016-04-21 |
20160108384 | Amylases, Nucleic Acids Encoding Them and Methods for Making and Using Them - In one aspect, the invention is directed to polypeptides having an amylase activity, polynucleotides encoding the polypeptides, and methods for making and using these polynucleotides and polypeptides. The polypeptides of the invention can be used as amylases to catalyze the hydrolysis of starch into sugars. | 2016-04-21 |
20160108385 | HYPERTHERMOSTABLE ENDOGLUCANASE BELONGING TO GH FAMILY 12 - A hyperthermostable endoglucanase including an endoglucanase catalytic domain, the endoglucanase catalytic domain including:
| 2016-04-21 |
20160108386 | CELLULOLYTIC ENZYMES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM - The invention is directed to polypeptides having any cellulolytic activity, e.g., a cellulase activity, e.g., endoglucanase, cellobiohydrolase, beta-glucosidase, xylanase, mannanse, β-xylosidase, arabinofuranosidase, and/or oligomerase activity, including thermostable and thermotolerant activity, and polynucleotides encoding these enzymes, and making and using these polynucleotides and polypeptides. The polypeptides of the invention can be used in a variety of pharmaceutical, agricultural, food and feed processing and industrial contexts. The invention also provides compositions or products of manufacture comprising mixtures of enzymes comprising at least one enzyme of this invention. | 2016-04-21 |
20160108387 | NOVEL METALLOPROTEASES - Aspects of the present compositions and methods relate to novel metalloproteases polynucleotides encoding the novel metalloprotease, compositions and methods for use thereof. | 2016-04-21 |
20160108388 | NOVEL METALLOPROTEASES - Aspects of the present compositions and methods relate to novel metalloproteases polynucleotides encoding the novel metalloprotease, compositions and methods for use thereof. | 2016-04-21 |
20160108389 | HIGH POTENCY PANCREATIN PHARMACEUTICAL COMPOSITIONS - The present disclosure provides high potency pharmaceutical compositions comprising high activity pancreatin enzymes. The invention is also directed to a process of producing HA-pancreatin enzymes and its compositions or dosage forms, and methods for their use. | 2016-04-21 |
20160108390 | COMPOSITION FOR STABILIZING EC-SOD AND METHOD OF STABILIZING EC-SOD USING THE SAME - The present invention relates to a composition for stabilizing extracellular superoxide dismutase (EC-SOD) protein and a method for stabilizing EC-SOD protein using the composition. More particularly, the present invention relates to a composition for stabilizing EC-SOD protein comprising bovine serum albumin (BSA), human serum albumin (HSA), polyethylene glycol (PEG) or fetal bovine serum (FBS) as an effective ingredient; a method for stabilizing EC-SOD protein using the inventive composition; and a method for preparing a stabilized EC-SOD protein using the inventive composition. | 2016-04-21 |
20160108391 | REAGENT COMPOSITIONS HAVING PYRIDINE-CARBOXYLIC ACID-STABILIZED ENZYMES, AS WELL AS METHODS OF MAKING AND USING THE SAME - Dry reagent compositions are disclosed that include one or more of an enzyme such as a dehydrogenase, a redox cofactor, an agent capable of eliciting at least one measurable change in a property of an indicator reagent in the presence of redox equivalents, an indicator reagent, and a pyridine-carboxylic acid, derivative or salt thereof. Also provided are diagnostic test elements including the reagent compositions for use in body fluid analysis. Further provided are methods of making test elements, as well as methods of body fluid analysis with such test elements. In the compositions, the pyridine-carboxylic acid, derivative or salt thereof attenuates, reduces or prevents a decrease of enzymatic activity of the at least one dehydrogenase under dry and/or humid conditions. | 2016-04-21 |
20160108392 | SOLID-CORE RING-MAGNET - A solid-core ring-magnet having one or more cavities is provided. The magnet can have an overall cylindrical shape or a rectangular-prism shape. In either case, a portion of cavity walls of the magnet are ring shaped, causing the magnetic field lines to emanate from the magnet in the shape of a ring. The diameter of the ring shaped cavities can be constant throughout, constant through a portion of the cavity, variant throughout, or variant through a portion of the cavity. The cavities open to the end of the magnet, and terminate toward the core of the magnet. Also provided are systems and kits having solid-core ring-magnets. Methods of purifying a macromolecule using the solid-core ring-magnets are also provided. | 2016-04-21 |
20160108393 | Rapid Nucleic Acid Extraction Method and Apparatus - A syringe device having a plunger beneath which is disposed a rupturable capsule containing a nucleic acid wash buffer and a rupturing mechanism for rupturing the capsule, wherein the capsule, syringe, plunger, and rupturing mechanism are so configured as to first apply pneumatic pressure to force a nucleic acid solution through a membrane and to thereafter rupture the capsule and force a first volume of the wash buffer through the membrane. | 2016-04-21 |
20160108394 | MOLECULAR IDENTITY TAGS AND USES THEREOF IN IDENTIFYING INTERMOLECULAR LIGATION PRODUCTS - Molecular identity tags and methods of marking target nucleic acids with molecular identity tags for identifying intermolecular ligation products. Terminal regions of linear target nucleic acids are marked with pairs of distinguishable molecular identity tags. Each linear target nucleic acid is marked with only one distinguishable pair. The terminal ends of the marked target nucleic acids are joined to generate circularized nucleic acids, thereby juxtaposing two molecular identity tags across the joined terminal ends. Circularized nucleic acids or downstream products thereof comprising juxtaposed unpaired molecular identity tags constitute intermolecular nucleic acid products that can be identified and eliminated from subsequent analyses of the nucleic acids. The molecular identity tags may comprise physically linked and non-physically linked pairs. Physically linked molecular identity tags designed for production and analysis of mate-pair libraries with next-generation sequencing platforms are provided. | 2016-04-21 |
20160108395 | CHIMERIC SINGLE-STRANDED ANTISENSE POLYNUCLEOTIDES AND DOUBLE-STRANDED ANTISENSE AGENT - Chimeric single-stranded polynucleotides and double-stranded antisense agents useful for modifying the expression of a target gene by means of an antisense effect are disclosed. The chimeric single-stranded antisense polynucleotide and double-stranded antisense agents comprise a central nucleotide region flanked by a first 5′-wing region and a first 3′-wing region of modified nucleotides, which are themselves flanked by a second 5′-wing region and/or a second 3′-wing region of nucleotides that have a low affinity for proteins and/or that have higher resistance to DNase or RNase than a natural DNA or RNA and are missing in a cell when the chimeric polynucleotide delivered. The double-stranded antisense agent further comprises a complementary strand annealed to the antisense strand. The polynucleotide can be used to modify RNA transcription levels, miRNA activity, or protein levels in cells. | 2016-04-21 |
20160108396 | OLIGOMERS TARGETING HEXANUCLEOTIDE REPEAT EXPANSION IN HUMAN C9ORF72 GENE - The disclosure relates to oligomers capable of targeting RNA expressed from the human C9ORF72 gene containing a pathogenic hexanucleotide repeat expansion. Such oligomers are useful for, among other things, reducing or eliminating C9ORF72 RNA and/or proteins translated therefrom, and treating or preventing diseases or disorders caused by, or associated with, hexanucleotide repeat expansion, including familial frontotemporal dementia (FTD) and familial amyotrophic lateral sclerosis (ALS). | 2016-04-21 |
20160108397 | TARGETING MICRORNAS FOR THE TREATMENT OF FIBROSIS - Provided herein are compositions and methods for the modulation of miR-214 for the treatment and/or prevention of fibrosis and fibroproliferative conditions. | 2016-04-21 |
20160108398 | Hydrophobically Modified Antisense Oligonucleotides Comprising a Ketal Group - The present invention concerns an oligonucleotide modified by substitution at the 3′ or the 5′ end by a moiety comprising at least one ketal functional group, wherein the ketal carbon of said ketal functional group bears two saturated or unsaturated, linear or branched, hydrocarbon chains comprising from 1 to 22 carbon atoms, and the use therefore as a medicament, in particular for use for treating cancer. | 2016-04-21 |
20160108399 | MODULATION OF HSP47 EXPRESSION - Provided herein are compositions, methods and kits for modulating expression of target genes, particularly heat shock protein 47 (hsp47). The compositions, methods and kits may include nucleic acid molecules (for example, short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA) or short hairpin RNA (shRNA)) that modulate a gene encoding hsp47, for example, the gene encoding human hsp47. The composition and methods disclosed herein may also be used in treating conditions and disorders associated with hsp47 such as liver fibrosis, pulmonary fibrosis, peritoneal fibrosis and kidney fibrosis. | 2016-04-21 |
20160108400 | Single-Stranded Nucleic Acid Molecule for Controlling Gene Expression - Provided is a novel nucleic acid molecule that is a single-stranded nucleic acid molecule including an expression inhibitory sequence that inhibits expression of a target gene. The single-stranded nucleic acid molecule includes, in sequence from the 5′ side to the 3′ side: a 5′ side region (Xc); an inner region (Z); and a 3′ side region (Yc). The inner region (Z) is composed of an inner 5′ side region (X) and an inner 3′ side region (Y) that are linked to each other. The 5′ side region (Xc) is complementary to the inner 5′ side region (X). The 3′ side region (Yc) is complementary to the inner 3′ side region (Y). At least one of the inner region (Z), the 5′ side region (Xc), and the 3′ side region (Yc) includes the expression inhibitory sequence. | 2016-04-21 |
20160108401 | COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF - The invention relates to iRNA, e.g., double-stranded ribonucleic acid (dsRNA), compositions targeting the complement component C5 gene, and methods of using such iRNA, e.g., dsRNA, compositions to inhibit expression of C5 and to treat subjects having a complement component C5-associated disease, e.g., paroxysmal nocturnal hemoglobinuria. | 2016-04-21 |
20160108402 | METHODS FOR DIAGNOSING AND TREATING LEARNING OR MENTAL DISORDERS - The present invention embraces methods for the diagnosis and treatment of learning or mental disorders such as schizophrenia using miR-25, miR-98, or miR-185. | 2016-04-21 |
20160108403 | NUCLEIC ACID APTAMERS - The present invention relates to optimized aptamers and methods of using these aptamers. | 2016-04-21 |
20160108404 | Method for Inhibiting HIV Replication in Mammal and Human Cells - The present invention describes a method to inhibit replication of the human immunodeficiency virus (HIV) by negatively modulating or altering the cytoskeleton, more precisely the proteins forming the intermediate cytoskeletal filaments, wherein the said proteins are vimentin and/or keratin-10. The replication of the virus is inhibited in human cells by intervening in the structure of these proteins. The present invention is also related to the use of agents, which comprise peptides and/or interfering RNA and/or lipidic compounds, said agents producing a negative modulation or alteration of the cytoskeleton to prevent or to treat the HIV infection. The invention provides means and methods for altering the cytoskeleton/filament structure of cells, as a result of which the infection of human cells by HIV is disturbed and can even be completely inhibited. The cytoskeleton is altered by reducing the amount of vimentin and/or keratin (e.g. by transcriptional control using interfering RNA) or by using peptides that disrupt the cytoskeleton. | 2016-04-21 |
20160108405 | LUNG CANCER DIAGNOSTICS AND THERAPEUTICS WITH MIR-660 - Provided are methods of treating lung cancer in a patient in need thereof. The method includes administration to the patient a composition comprising a therapeutically effective amount of a compound that reduces the expression level of E3 ubiquitin-protein ligase MDM2. The compound in certain instances is a miR-660 miRNA, or a functional variant thereof. The patient in need of treatment in certain instances expresses miR-660 in a lung tissue sample or biological fluid sample at a level lower as compared to a control level derived from a subject or plurality of subjects that do not have lung cancer, or as compared to a control level derived from a lung cancer patient or plurality thereof, that have been given a favorable prognosis; expresses MDM2 at a higher level in a lung tissue sample or biological fluid sample as compared to a control level derived from a subject or plurality of subjects that do not have lung cancer, or as compared to a control level derived from a lung cancer patient or plurality thereof that have been given a favorable prognosis; and/or expresses p53 in a lung tissue sample or a biological fluid sample below a control level derived from a lung tumor tissue sample, or plurality thereof, or a biological fluid sample, or plurality thereof, obtained from a patient that has a favorable lung cancer prognosis; or a control level derived from a healthy subject. | 2016-04-21 |
20160108406 | METHOD OF REGULATING CFTR EXPRESSION AND PROCESSING - The present invention relates to methods of reducing ΔF508-CFTR ubiquitination or degradation, or increasing ΔF508-CFTR processing or function in a CF cell comprising contacting the cell with a therapeutic agent that inhibits NEDD8, FBXO2, and/or SYVN1 expression in the cell. | 2016-04-21 |
20160108407 | IMPROVED SURFACE DISPLAY OF FUNCTIONAL PROTEINS IN A BROAD RANGE OF GRAM NEGATIVE BACTERIA - The present invention relates to a method for the surface display of a recombinant polypeptide on the surface of a host cell, said method comprising the steps: (a) providing a host cell transformed with a nucleic acid fusion operatively linked with an expression control sequence, said nucleic acid fusion comprising: (i) a portion encoding a signal peptide, (ii) a portion encoding the recombinant polypeptide to be displayed, (iii) a portion encoding a transmembrane linker, and (iv) a portion encoding the trans porter domain of an EhaA protein, and (b) culturing the host cell under conditions wherein the nucleic acid fusion is expressed and the expression product comprising the recombinant polypeptide is displayed on the surface of the host cell. | 2016-04-21 |
20160108408 | METHOD FOR DIRECTIONAL CLONING - Described herein are techniques for directional cloning an insert DNA segments into a target vector. The techniques mix the target vector, the insert DNA segment, a restriction enzyme, and a DNA ligase to generate a recombinant DNA molecule. | 2016-04-21 |
20160108409 | Method for improved protein production in filamentous fungi - The present invention relates to a method for genetically modifying a filamentous fungus host for improved protein production. The method comprises that a filamentous fungus host is genetically modified to overexpress or to be deficient of specific genes. The invention relates also to the modified hosts. Furthermore, the invention relates to a method for improved production or for producing an improved composition of proteins, such as cellulases, hemicellulases, other proteins involved in the degradation of lignocellulosic material, or other proteins, in a filamentous fungus host. | 2016-04-21 |
20160108410 | MODULAR SYNTHETIC GAL1 PROMOTER AND USE THEREOF - The present invention relates to a nucleic acid molecule that comprises at least one synthetic GAL1 core promoter containing one or more ligand responsive operator sequences, preferably one or more FadR operator sites; at least one upstream enhancer element (UEE); and at least one nucleotide sequence encoding for one or more genes of interest; wherein the at least one synthetic GAL1 core promoter is operably linked to the at least one nucleotide sequence encoding for one or more genes of interest and the at least one UEE is operably linked to the at least one synthetic GAL1 core promoter. Also encompassed are expression systems and recombinant cells that include these nucleic acid molecules and methods that use these nucleic acid molecules, expression systems or cells. | 2016-04-21 |
20160108411 | METHODS AND COMPOSITIONS FOR TRANSGENIC PLANTS WITH ENHANCED COLD TOLERANCE, ABILITY TO FLOWER WITHOUT VERNALIZATION REQUIREMENT AND IMPACTED FERTILITY - The present invention provides transgenic plants having increased tolerance to cold and altered flowering characteristics. Also provided are methods and compositions for producing said transgenic plants. | 2016-04-21 |
20160108412 | Modified FRT Recombination Site Libraries and Methods of Use - Methods and compositions using populations of randomized modified FRT recombination sites to identify, isolate and/or characterize modified FRT recombination sites are provided. Kits comprising the library populations of FRT sites are also provided, as are methods to make a library of modified FRT recombination sites. The recombinogenic modified FRT recombination sites can be employed in a variety of methods for targeted recombination of polynucleotides of interest. | 2016-04-21 |
20160108413 | ENHANCED SELECTIVE EXPRESSION OF TRANSGENES IN FIBER PRODUCING PLANTS - Methods and means are provided to enhance the selective expression of transgenes under control of a fiber-selective promoter, in fiber cells, particularly cotton fiber cells by including target sites for naturally occurring microRNAs with a specific expression profile, particularly with a differential expression profile between cells leading to fibers and other cells of the fiber producing plant, into the transcribed region of genes of interest. | 2016-04-21 |
20160108414 | GROWTH-RELATED ENOX PROTEINS FROM PLANTS WITH YIELD ENHANCEMENT POTENTIAL, SEQUENCES AND METHODS - Described are compositions of matter and methods useful for increasing the yield of transgenic agricultural crops. Sequence information of ENOX proteins and methods for transfection are disclosed. Additionally, small molecule activators of ENOX proteins are disclosed. Sequence information from ENOX proteins from the yeast | 2016-04-21 |
20160108415 | MANIPULATION OF GLUTAMINE SYMTHETASES (GS) TO IMPROVE NITROGEN USE EFFICIENCY AND GRAIN YIELD IN HIGHER PLANTS - The present invention provides polynucleotides and related polypeptides of the protein GS. The invention provides genomic sequence for the GS gene. GS is responsible for controlling nitrogen utilization efficiency in plants. Glutamine synthase sequences are provided for improving grain yield and plant growth. The invention further provides recombinant expression cassettes, host cells and transgenic plants. | 2016-04-21 |
20160108416 | ATSP1, AN E3 UBIQUITIN LIGASE, AND ITS USE - The invention relates to plants with improved phenotypes and related methods. These improved phenotypes are conferred by altering the expression of the SP1 gene which is involved in plastid development or altering the activity of the SP1 protein. | 2016-04-21 |
20160108417 | PLANT WITH REDUCED PROTEIN PRODUCTIVITY IN SEEDS AND METHOD FOR PRODUCING SAME - According to the present invention, a gene having a novel function that can cause an increase or decrease in seed protein content is searched for. A chimeric protein obtained by fusing a transcription factor consisting of a protein comprising an amino acid sequence shown in any of the even-numbered SEQ ID NOS: 1 to 76 and a functional peptide capable of converting an arbitrary transcription factor into a transcriptional repressor or a transcription factor consisting of a protein comprising an amino acid sequence shown in any of the even-numbered SEQ ID NOS: 77 to 84 is expressed in a plant. | 2016-04-21 |
20160108418 | PLANT WITH REDUCED PROTEIN PRODUCTIVITY IN SEEDS AND METHOD FOR PRODUCING SAME - According to the present invention, a gene having a novel function that can cause an increase or decrease in seed protein content is searched for. A chimeric protein obtained by fusing a transcription factor consisting of a protein comprising an amino acid sequence shown in any of the even-numbered SEQ ID NOS: 1 to 76 and a functional peptide capable of converting an arbitrary transcription factor into a transcriptional repressor or a transcription factor consisting of a protein comprising an amino acid sequence shown in any of the even-numbered SEQ ID NOS: 77 to 84 is expressed in a plant. | 2016-04-21 |
20160108419 | PLANTS HAVING ONE OR MORE ENHANCED YIELD-RELATED TRAITS AND A METHOD FOR MAKING THE SAME - A method for enhancing various economically important yield-related traits in plants is provided. More specifically, a method for enhancing one or more yield-related traits in plants by modulating expression in a plant of a nucleic acid encoding a POI (Protein Of Interest) polypeptide is provided. | 2016-04-21 |
20160108420 | PLANTS HAVING INCREASED DESICCATION TOLERANCE, INCREASED DROUGHT TOLERANCE OR INCREASED WATER USE EFFICIENCY - A transgenic plant engineered to have increased desiccation tolerance, increased drought tolerance or increased water use efficiency, the plant transformed with an artificial DNA construct comprising a transcribable nucleic acid molecule encoding a polypeptide requiring both ABA and ABI3 to influence desiccation tolerance. Also provided are DNA constructs and methods of producing a transgenic plant engineered to have increased desiccation tolerance, increased drought tolerance or increased water use efficiency. | 2016-04-21 |
20160108421 | METHOD FOR PRODUCING STRESS TOLERANT TRANSGENIC PLANT BY SILENCING A GENE ENCODING CALCIUM-DEPENDENT LIPID-BINDING PROTEIN WITH C2 DOMAIN AND APPLICATIONS OF THE SAME - A method for silencing rice plant, includes the steps of: identifying a first nucleotide sequence from | 2016-04-21 |
20160108422 | HERBICIDE TOLERANCE GENES AND METHODS OF USE THEREOF - Polypeptides and recombinant DNA molecules useful for conferring tolerance to AOPP herbicides, phenoxy acid herbicides, and pyridinyloxy acid herbicides are provided in the present invention, as well as herbicide tolerant transgenic plants, seeds, cells, and plant parts containing the recombinant DNA molecules, as well as methods of using the same. | 2016-04-21 |
20160108423 | HERBICIDE-TOLERANT PLANTS - The present invention provides herbicide-tolerant plants. The present invention also provides methods for controlling the growth of weeds by applying an herbicide to which herbicide-tolerant plants of the invention are tolerant. Plants of the invention may express an acetyl-Coenzyme A carboxylase enzyme that is tolerant to the action of acetyl-Coenzyme A carboxylase enzyme inhibitors | 2016-04-21 |
20160108424 | METHOD FOR INCREASING PATHOGEN RESISTANCE IN PLANTS - The invention relates to a method of increasing the resistance to one or more pathogens, preferably fungal or bacterial pathogens, in a monocotyledonous or dicotyledonous plant or a part of a plant, for example in an organ, tissue, a cell or a part of a plant cell, for example in an organelle, wherein a DNA sequence which codes for YODA protein or wherein an endogenous DNA sequence which codes for a YODA protein is increased in the plant or plant cell in comparison with the original, or wild-type, plant. The invention also relates to plants, to parts of a plant, for example an organ, tissue, a cell or a part of a plant cell, for example an organelle, which are obtained by the above methods, and to the corresponding propagation material. | 2016-04-21 |